Pericarditis in contemporary therapeutic clinic: nosological spectrum, approaches to diagnosis and treatment
- 作者: Blagova O.1, Nedostup A.1, Sedov V.1, Kogan E.1, Alijeva I.1, Sorokin G.1, Sarkisova N.1
-
隶属关系:
- Sechenov First Moscow State Medical University (Sechenov University)
- 期: 卷 92, 编号 12 (2020)
- 页面: 10-18
- 栏目: Articles
- URL: https://journals.rcsi.science/0040-3660/article/view/60247
- DOI: https://doi.org/10.26442/00403660.2020.12.200432
- ID: 60247
如何引用文章
全文:
详细
Aim. To analyze the register of pericarditis in a therapeutic clinic, to evaluate their nosological spectrum, to optimize approaches to diagnosis and treatment.
Materials and methods. For the period 2007–2018, the register includes 76 patients with the diagnosis of “pericarditis” (average age 53.1±15.7 years, 20–85 years, 46 female). Patients with hydropericardium were not included in the register. Diagnostic puncture of pericardium was carried out in 5 patients, pleural puncture – in 11 patients. Morphological diagnostics included endomyocardial/ intraoperative biopsy of myocardium (n=4/2), thoracoscopic/intraoperative biopsy of pericardium (n=1/6), pleural puncture (n=5), transbronchial (n=1), thoracoscopic biopsy of intrathoracic lymph nodes (n=2), lung (n=1), supraclavicular lymph node biopsy (n=1), salivary gland (n=1), subcutaneous fat and rectum biopsy per amyloid (n=6/1). The genome of cardiotropic viruses, level of anti-heart antibodies, C-reactive protein, antinuclear factor, rheumatoid factor (antibodies to cyclic citrullinized peptide), antibodies to neutrophil cytoplasm were determined, extractable nuclear antigens (ENA), protein immunoelectrophoresis, diaskin test, computed tomography of lungs and heart, cardiac magnetic resonance imaging, oncologic search.
Results. The following forms of pericarditis were verified: tuberculosis (14%, including in combination with hypertrophic cardiomyopathy – HCM), acute / chronic viral (8%) and infectious immune (38%), including perimyocarditis in 77%, pericarditis associated with mediastinum lymphoma/sarcoma (4%), sarcoidosis (3%), diffuse diseases of connective tissue and vasculitis (systemic lupus erythematosus, rheumatoid arthritis, diseases of Horton, Takayasu, Shegren, Wegener, 12%), leukoclastic vasculitis, Loeffler’s endomyocarditis, AL-amyloidosis, thrombotic microangiopathy (1% each), HCM (8%), coronary heart disease (constriction after repeated punctures and suppuration; postinfection and immune, 4%), after radiofrequency catheter ablation and valve prosthetics (2%). Tuberculosis was the main causes of constrictive pericarditis (36%). Treatment included steroids (n=39), also in combination with cytostatics (n=12), anti-tuberculosis drugs (n=9), acyclovir/ganclovir (n=14), hydroxychloroquine (n=23), colchicine (n=13), non-steroidal anti-inflammatory drugs (n=21), L-tyroxine (n=5), chemotherapy (n=1). In 36 patients different types of therapy were combined. Treatment results observed in 55 patients. Excellent and stable results were achieved in 82% of them. Pericardiectomy/pericardial resection was successfully performed in 8 patients. Lethality was 13.2% (10 patients) with an average follow-up 9 [2; 29.5] months (up to 10 years). Causes of death were chronic heart failure, surgery for HCM, pulmonary embolism, tumor.
Conclusion. During a special examination, the nature of pericarditis was established in 97% of patients. Morphological and cytological diagnostics methods play the leading role. Tuberculosis pericarditis, infectious-immune and pericarditis in systemic diseases prevailed. Infectious immune pericarditis is characterized by small and medium exudate without restriction and accompanying myocarditis. Steroids remain the first line of therapy in most cases. Hydroxychloroquine as well as colchicine can be successfully used in moderate / low activity of immune pericarditis and as a long-term maintenance therapy after steroid stop.
作者简介
O. Blagova
Sechenov First Moscow State Medical University (Sechenov University)
编辑信件的主要联系方式.
Email: blagovao@mail.ru
ORCID iD: 0000-0002-5253-793X
д.м.н., проф.
俄罗斯联邦, MoscowA. Nedostup
Sechenov First Moscow State Medical University (Sechenov University)
Email: blagovao@mail.ru
ORCID iD: 0000-0002-5426-3151
м.н., проф.
俄罗斯联邦, MoscowV. Sedov
Sechenov First Moscow State Medical University (Sechenov University)
Email: blagovao@mail.ru
ORCID iD: 0000-0003-2326-9347
д.м.н., проф.
俄罗斯联邦, MoscowE. Kogan
Sechenov First Moscow State Medical University (Sechenov University)
Email: blagovao@mail.ru
ORCID iD: 0000-0002-1107-3753
д.м.н., проф.
俄罗斯联邦, MoscowI. Alijeva
Sechenov First Moscow State Medical University (Sechenov University)
Email: blagovao@mail.ru
ORCID iD: 0000-0002-3338-0762
врач-кардиолог
俄罗斯联邦, MoscowG. Sorokin
Sechenov First Moscow State Medical University (Sechenov University)
Email: blagovao@mail.ru
ORCID iD: 0000-0002-1013-9706
аспирант
俄罗斯联邦, MoscowN. Sarkisova
Sechenov First Moscow State Medical University (Sechenov University)
Email: blagovao@mail.ru
ORCID iD: 0000-0002-5979-1180
зав. кардиологическим отд-нием
俄罗斯联邦, Moscow参考
- Maisch B, Rupp H, Ristic A, Pankuweit S. Pericardioscopy and epi- and pericardial biopsy − a new window to the heart improving etiological diagnoses and permitting targeted intrapericardial therapy. Heart Fail Rev. 2013;18(3):317-28. doi: 10.1007/s10741-013-9382-y
- Айвазьян С.А., Медведев А.П., Косоногов А.Я., Сидоров М.А. Опыт применения перикардиоскопии для диагностики и лечения заболеваний перикарда. Мед. альманах. 2011;6:236-7 [Aivazyan SA, Medvedev AP, Kosonogov AY, Sidorov MA. The experience of the usage of pericardioscopy for diagnostics and treatment of diseases of pericardium. Medizinskij al’manakh. 2011;6:236-7 (In Russ.)].
- Gouriet F, Levy PY, Casalta JP, et al. Etiology of Pericarditis in a Prospective Cohort of 1162 Cases. Am J Med. 2015;128(7):784.e1-8. doi: 10.1016/j.amjmed.2015.01.040
- Демин А.А., Дробышева В.П. Болезни перикарда. Рос. кардиологический журн. 2016;1:90-8 [Dyomin AA, Drobysheva VP. Pericardium diseases. Russian Journal of Cardiology. 2016;1:90-8 (In Russ.)]. doi: 10.15829/1560-4071-2016-1-90-98
- Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921-64. doi: 10.1093/eurheartj/ehv318
- Благова О.В., Алиева И.Н., Недоступ А.В. и др. Экссудативно-констириктивный туберкулезный перикардит в сочетании с артритом в практике кардиолога: торакоскопическая биопсия как путь к диагнозу и лечению. Терапевтический архив. 2018;90(9):81-7 [Blagova OV, Alijeva IN, Nedostup AV, et al. Exudative-constrictive tuberculous pericarditis in combination with arthritis in cardiologist practice: thoracoscopic biopsy as a diagnosis and treatment method. Therapeutic Archive. 2018;90(9):81-7. (In Russ.)] doi: 10.26442/terarkh201890981-87
- Благова О.В., Царегородцев Д.А., Недоступ А.В. и др. Распространенный констриктивный полисерозит тяжелого течения у больного ревматоидным артритом. Терапевтический архив. 2010;82(6):56-61 [Blagova OV, Tsaregorodtsev DA, Nedostup AV, et al. Severe disseminated constrictive polyserositis in a patient with rheumatoid arthritis. Therapeutic Archive. 2010;82(6):56-61 (In Russ.)].
- Maisch B; European Society of Cardiology. Progress or regress or both? ESC guidelines on pericardial diseases 2015. Herz. 2015; 40(8):1061-9. doi: 10.1007/s00059-015-4395-z
- Maestroni S, Di Corato PR, Cumetti D, et al. Recurrent pericarditis: autoimmune or autoinflammatory? Autoimmun Rev. 2012;12(1):60-5. doi: 10.1016/j.autrev.2012.07.023
- Pankuweit S, Stein A, Karatolios K, et al. Viral genomes in the pericardial fluid and in peri- and epicardial biopsies from a German cohort of patients with large to moderate pericardial effusions. Heart Fail Rev. 2013;18(3):329-36. doi: 10.1007/s10741-013-9375-x
- Новиков Ю.И., Али Шах Миан Саид, Стулова М.А. О связи гипертрофической кардиомиопатии с вирусными и идиопатическими миоперикардитами. Клиническая медицина. 2000;9:15-21 [Novikov IuI, Mian Said ASh, Stulova MA. Hypertrophic cardiomyopathy and viral, idiopathic myopericarditis. Klin. Med. 2000;78(9):15-21 (In Russ.)]
- Okayama S, Soeda T, Seno A, et al. Rare concurrence of apical hypertrophic cardiomyopathy and effusive constrictive pericarditis. Open Cardiovasc Med J. 2011;5:99-102. doi: 10.2174/1874192401105010099
- Witt CM, Eleid MF, Nishimura RA. Diagnosis of constrictive pericarditis obscured by hypertrophic cardiomyopathy: Back to basics. Catheter Cardiovasc Interv. 2015; 86(3):536-9. doi: 10.1002/ccd.25873
- Dyrda K, Piers SR, van Huls van Taxis CF, et al. Influence of steroid therapy on the incidence of pericarditis and atrial fibrillation after percutaneous epicardial mapping and ablation for ventricular tachycardia. Circ Arrhythm Electrophysiol. 2014;7(4):671-6. doi: 10.1161/CIRCEP.113.001148
- Sedaghat-Hamedani F, Zitron E, Kayvanpour E, et al. Post cardiac injury syndrome after initially uncomplicated CRT-D implantation: a case report and a systematic review. Clin Res Cardiol. 2014; 103(10):781-9. doi: 10.1007/s00392-014-0716-0
- Imazio M, Belli R, Brucato A, et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet. 2014; 383(9936):2232-7. doi: 10.1016/S0140-6736(13)62709-9
- Smilde BJ, Woudstra L, Fong Hing G, et al. Colchicine aggravates coxsackievirus B3 infection in mice. Int J Cardiol. 2016;216:58-65. doi: 10.1016/j.ijcard.2016.04.144
- Maestroni S, Imazio M, Valenti A, et al. Is colchicine really harmful in viral myocarditis? Int J Cardiol. 2017;229:42. doi: 10.1016/j.ijcard.2016.10.031